News 2019 / 2

There has been increasing interest in exosomes and other extracellular vesicles as possible biomarkers for disease and as novel cell-cell communicators. Exosomes carry a variety of cargo such as mRNA, non-coding RNA, proteins and lipids and are thought to have a functional role in both normal physiology and pathological conditions. They are released from many cell types and circulate in multiple biofluids in the body, including plasma, cerebrospinal fluid, and urine

Addition of TransFix at the point of blood collection may reduce the negative impact of platelet exosome release, giving researchers, a better idea of the events happening in patient samples.

TransFix is a fixative designed for stabilizing cell surface antigens until sample processing and analysis can be performed. Exosomes in the blood are stable even after freeze/thaw cycles. However, plasma processing at 4C, may cause more exosomes to be released from platelets. This exosome release complicates data generated by scientists looking for rare exosomal biomarker events. The study below, demonstrates that addition of TransFix at the point of blood collection may reduce the negative impact of platelet exosome release, giving researchers, a better idea of the events that may be happening in patient samples.

Case Study: A Comparison of Exosome Isolation from Blood Collection with Conventional EDTA and TransFix/EDTA Vacuum Blood Collection Tubes

Summary

The exosome profile (CD9, CD63, and CD81 tetraspanin proteins) of normal serum with and without the use TransFix containing tubes, after storage at 4°C for 4 days was evaluated. Western blot analysis showed detection of all three exosome tetraspanin proteins. NanoSight analysis showed that the TransFix tubes were more likely to capture particles of the correct size range for exosomes and that the particle concentration is higher for the EDTA samples than the TransFix samples. This higher concentration in the EDTA plasma sample is believed to be due to the release of exosomes from platelets during processing and storage at 4°C.

  • Western blot analysis showed detection of all three exosome tetraspanin proteins.
  • NanoSight analysis showed that the TransFix tubes were more likely to capture particles of the correct size range for exosomes (1).
  • The particle concentration is higher for the EDTA samples than the TransFix samples. This higher concentration in the EDTA plasma sample is believed to be due to the release of exosomes from platelets during processing and storage at 4°C (2)(3).

The addition of TransFix at the point of blood collection may reduce the negative impact of platelet exosome release, providing a more accurate picture of the exosome content of samples.

Method

On day 0 a blood draw from donors was performed. Each donor provided 3 x 9 ml of blood drawn into conventional EDTA Vacuum Blood Collection Tubes and 3 x 9 ml of blood drawn into the TransFix/EDTA vacuum blood collection tubes, (Product Code TVT-09-50) from a single venipuncture. The tubes were centrifuged at 300 x g for 20 minutes at room temperature. The upper plasma layer was separated and divided into 1 ml aliquots and samples were stored at 4°C. On day 4, exosomes were isolated from the EDTA and TransFix plasma samples (using an ExoCap™ Streptavidin Kit, MBL International). The isolated exosomes were then analysed by western blot to visualize exosome proteins and by NanoSight to determine the exosome size and concentration.

References

Graça Raposo, Willem Stoorvogel (2013). Review: Extracellular vesicles: Exosomes, microvesicles, and friends [online] 200 (4): 373 available at http://jcb.rupress.org/content/200/4/373#ref-104

Heijnen, F.G. et al (1999). Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and Granules. Blood. Volume 94, p 3791-3799. Available at http://www.bloodjournal.org/content/94/11/3791?sso-checked=true

Aatonen, A.T et al (2014). Journal of Extracellular Vesicles. Volume 3, 2014 - Issue 1. Available at https://www.tandfonline.com/doi/full/10.3402/jev.v3.24692

     

Get further info from: info@bioleague.de